Neurophet Expands US Market Presence with New Brain Disorder Diagnostic Devices

Medical technology firm Neurophet has supplied its AQUA and AQUA AD Plus systems to a US clinic, marking a strategic expansion in the American brain disorders diagnostics sector.

27 Aug, 13:30 — 27 Aug, 13:30

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual2d ago

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market - Taiwan News

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market Taiwan News

Read full article →

PERSPECTA

PERSPECTA

Neurophet Expands US Market Presence with New Brain Disorder Diagnostic Devices

Sources

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market - Taiwan News

Related Stories

NASA Prepares to Launch Nancy Grace Roman Space Telescope

Serbia Inaugurates First Humanoid Robot Manufacturing Plant in Šabac

Chinese Chipmaker CXMT Sues Pentagon Over Military Blacklist Designation

AI Demand Fuels Record Chipmaker Profits Amid Broader Cost Pressures

PERSPECTA